MBAA in the News: Trump’s Drug Pricing Policy Deprives Patients in Europe of New Treatments (Bloomberg)
Going forward, the biotech will prioritize European countries “where we believe there is opportunity for innovation to be recognized” like France, Italy, Spain and the UK, (Madrigal) Chief Executive Officer…
